ViiV's award-winning HIV theater show set for New York run by Beth Snyder Bulik Tuesday, September 10, 2019 ViiV Healthcare’s award-winning theatrical performance about the real-life experiences of black gay men living with HIV debuts in New York this week.
Pfizer pays $700K to settle copay coupon probe by Angus Liu Friday, October 12, 2018 Pfizer will pay $700,000 to settle New York AG charges that it misled consumers with "pay no more than" copay coupons.
First U.S.-Cuba biotech JV debuts with cancer vaccines by Angus Liu Monday, October 1, 2018 Roswell Park Comprehensive Cancer Center has announced a biotech joint venture with Havana-based Center for Molecular Immunology.
Merck, Novartis discrimination suits reignite public attention by Angus Liu Thursday, June 28, 2018 A lawsuit against Merck alleges the company discriminated against female sales reps while the lead plaintiffs also pursue their own pregnancy discrimination allegations.
Groundwork underway for Athenex $200M New York plant by Joseph Keenan Tuesday, May 29, 2018 Athenex has begun site preparation for its $200 million manufacturing facility in Dunkirk, New York.
Pfizer plants its new HQ flag at The Spiral with a view by Tracy Staton Tuesday, April 10, 2018 It’s official: Pfizer’s New York headquarters will move to Hudson Yards and its slick new skyscraper, The Spiral.
Sen. Sanders wants more from Congress on opioid issue by Eric Sagonowsky Tuesday, February 6, 2018 Sen. Sanders said it's time for Congress to force CEOs to testify on the opioid crisis as lawyers negotiate a potential settlement.
New York looks at making industry handle drug disposal by Eric Palmer Tuesday, January 16, 2018 A new front has opened in the fight to make the pharma industry responsible for disposing of unused meds, this time in New York.
Novartis plant in New York bought for $18M, then resold for $30M by Eric Palmer Tuesday, September 19, 2017 The vacant Novartis manufacturing facility in Suffern, New York, sold for $18 million to a buyer who then resold it to a developer for $30 million.
BMS, Pfizer prevail in 20 more Eliquis bleeding cases by Eric Sagonowsky Monday, July 31, 2017 Bristol-Myers Squibb and Pfizer are riding a hot streak defending against Eliquis liability lawsuits, prevailing in several dozen recent cases.
